Lipocine Inc. (LPCN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lipocine Inc.

    NASDAQ: LPCN · Real-Time Price · USD
    2.73
    0.05 (1.87%)
    At close: Sep 26, 2025, 1:13 PM

    Lipocine Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 11.2M -2.85M 500K 16.14M
    Cost of Revenue
    		 7.35M 10.18M n/a n/a
    Gross Profit
    		 3.85M -13.03M 500K 16.14M
    Operating Income
    		 -1.16M -17.93M -12.12M 3.15M
    Interest Income
    		 1.15M 1.37M 572.58K 67.7K
    Pretax Income
    		 9.03K -16.35M -10.76M -634.2K
    Net Income
    		 8.35K -16.35M -10.76M -634.4K
    Selling & General & Admin
    		 5M 4.9M 4.06M 5.33M
    Research & Development
    		 7.35M 10.18M 8.56M 7.67M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 12.35M 15.08M 11.8M 16.64M
    Interest Expense
    		 n/a n/a 27.1K 203.29K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 12.35M 15.08M 11.8M 16.64M
    Income Tax Expense
    		 681.00 755.00 681.00 200.00
    Shares Outstanding (Basic)
    		 5.34M 5.27M 4.99M 3.3M
    Shares Outstanding (Diluted)
    		 5.42M 5.27M 5.26M 5.15M
    EPS (Basic)
    		 0.00 -3.14 -2.15 -0.19
    EPS (Diluted)
    		 -0.00 -3.14 -2.05 -0.12
    EBITDA
    		 -1.11M -17.9M -10.72M -430.53K
    EBIT
    		 -1.16M -17.93M -10.73M -430.91K
    Depreciation & Amortization
    		 41.11K 28.66K 9.45K 380.00

    Add to Watchlist